Pyrimidine salvage in trypanosoma brucei bloodstream forms and the trypanocidal action of halogenated pyrimidines

Molecular Pharmacology

Volumn 83, Issue 2, 2013, Pages 439-453

  Ali, Juma A M ^a,b   Creek, Darren J ^a,c   Burgess, Karl ^a   Allison, Harriet C ^d   Field, Mark C ^d   Mäser, Pascal ^e   De Koning, Harry P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Al Jabal Al Gharbi University   (Libyan Arab Jamahiriya)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE; FLOXURIDINE DERIVATIVE; FLUORINE; FLUOROOROTIC ACID; FLUOROPYRIMIDINE; FLUOROURACIL; NUCLEIC ACID; NUCLEOSIDE TRANSPORTER; PYRIMIDINE DERIVATIVE; THYMIDINE; URACIL; URIDINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD FLOW; CLONE; CONTROLLED STUDY; DRUG MECHANISM; DRUG METABOLISM; HALOGENATION; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA BRUCEI;

BIOLOGICAL TRANSPORT; FLUOROURACIL; GENOME-WIDE ASSOCIATION STUDY; GLYCOSYLATION; NUCLEOSIDE TRANSPORT PROTEINS; PYRIMIDINES; TRYPANOSOMA BRUCEI BRUCEI; URACIL; URIDINE;

EID: 84872712111     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.082321     Document Type: Article

References (54)

1. Al-Salabi MI, Wallace LJM, Lüscher A, Mäser P, Candlish D, Rodenko B, Gould MK, Jabeen I, Ajith SN, and De Koning HP (2007) Molecular interactions underlying the unusually high adenosine affinity of a novel Trypanosoma brucei nucleoside transporter. Mol Pharmacol 71:921-929.
2. Arakaki TL, Buckner FS, and Gillespie JR et al. (2008) Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies. Mol Microbiol 68:37-50.
3. Baird JK (2005) Effectiveness of antimalarial drugs. N Engl J Med 352:1565-1577.
4. Bellofatto V (2007) Pyrimidine transport activities in trypanosomes. Trends Parasitol 23:187-189, discussion 190.
5. Berg M, Kohl L, and Van der Veken P et al. (2010) Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis. Antimicrob Agents Chemother 54:1900-1908.
6. Bernier-Villamor V, Camacho A, Hidalgo-Zarco F, Pérez J, Ruiz-Pérez LM, and González-Pacanowska D (2002) Characterization of deoxyuridine 59-triphosphate nucleotidohydrolase from Trypanosoma cruzi. FEBS Lett 526:147-150.
7. Castillo-Acosta VM, Estévez AM, Vidal AE, Ruiz-Perez LM, and González-Pacanowska D (2008) Depletion of dimeric all - a dUTPase induces DNA strand breaks and impairs cell cycle progression in Trypanosoma brucei. Int J Biochem Cell Biol 40:2901-2913.
8. Ceilley RI (2012) Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders. J Dermatolog Treat 23: 83-89.
9. Creek DJ, Jankevics A, Breitling R, Watson DG, Barrett MP, and Burgess KEV (2011) Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. Anal Chem 83:8703-8710.
10. Creek DJ, Jankevics A, Burgess KEV, Breitling R, and Barrett MP (2012) IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data. Bioinformatics 28: 1048-1049.
11. De Koning HP (2001) Transporters in African trypanosomes: role in drug action and resistance. Int J Parasitol 31:512-522.
12. De Koning HP (2007) Pyrimidine transporters of protozoa - A class apart (Editorial)? Trends Parasitol 23:190.
13. De Koning HP and Jarvis SM (1998) A highly selective, high-affinity transporter for uracil in Trypanosoma brucei brucei: evidence for proton-dependent transport. Biochem Cell Biol 76:853-858.
14. De Koning HP and Jarvis SM (1999) Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs. Mol Pharmacol 56:1162-1170.
15. De Koning HP, Bridges DJ, and Burchmore R (2005) Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy. FEMS Microbiol Rev 29: 987-1020.
16. De Koning HP, Anderson LF, Stewart M, Burchmore RJ, Wallace LJM, and Barrett MP (2004) The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes. Antimicrob Agents Chemother 48:1515-1519.
17. Donelson JE (2003) Antigenic variation and the African trypanosome genome. Acta Trop 85:391-404.
18. Eddy SR (2009) A new generation of homology search tools based on probabilistic inference. Genome Inform 23:205-211.
19. Fijolek A, Hofer A, and Thelander L (2007) Expression, purification, characterization, and in vivo targeting of trypanosome CTP synthetase for treatment of African sleeping sickness. J Biol Chem 282:11858-11865.
20. French JB, Yates PA, Soysa DR, Boitz JM, Carter NS, Chang B, Ullman B, and Ealick SE (2011) The Leishmania donovani UMP synthase is essential for promastigote viability and has an unusual tetrameric structure that exhibits substrate-controlled oligomerization. J Biol Chem 286:20930-20941.
21. Galmarini CM, Jordheim L, and Dumontet C (2003) Pyrimidine nucleoside analogs in cancer treatment. Expert Rev Anticancer Ther 3:717-728.
22. Gonzales JL, Chacon E, Miranda M, Loza A, and Siles LM (2007) Bovine trypanosomosis in the Bolivian Pantanal. Vet Parasitol 146:9-16.
23. Gould MK, Vu XL, Seebeck T, and De Koning HP (2008) Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay. Anal Biochem 382:87-93.
24. Gudin S, Quashie NB, Candlish D, Al-Salabi MI, Jarvis SM, Ranford-Cartwright LC, and De Koning HP (2006) Trypanosoma brucei: A survey of pyrimidine transport activities. Exp Parasitol 114:118-125.
25. Gutteridge WE and Trigg PI (1970) Incorporation of radioactive precursors into DNA and RNA of Plasmodium knowlesi in vitro. J Protozool 17:89-96.
26. Hammond DJ and Gutteridge WE (1982) UMP synthesis in the kinetoplastida. Biochim Biophys Acta 718:1-10.
27. Harkiolaki M, Dodson EJ, Bernier-Villamor V, Turkenburg JP, González-Paca-nowska D, and Wilson KS (2004) The crystal structure of Trypanosoma cruzi dUTPase reveals a novel dUTP/dUDP binding fold. Structure 12:41-53.
28. Hassan HF and Coombs GH (1988) Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol Rev 4:47-83.
29. Hofer A, Ekanem JT, and Thelander L (1998) Allosteric regulation of Trypanosoma brucei ribonucleotide reductase studied in vitro and in vivo. J Biol Chem 273: 34098-34104.
30. Hofer A, Steverding D, Chabes A, Brun R, and Thelander L (2001) Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness. Proc Natl Acad Sci USA 98:6412-6416.
31. Hoffmann HH, Kunz A, Simon VA, Palese P, and Shaw ML (2011) Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci USA 108:5777-5782.
32. Königk E (1976) Comparative aspects of nucleotide biosynthesis in parasitic protozoa, in Biochemistry of Parasites and Host-Parasite Relationships (Van den Bossche H, ed, ed) pp 51-58, North Holland, Amsterdam.
33. Larson ET, Mudeppa DG, and Gillespie JR et al. (2010) The crystal structure and activity of a putative trypanosomal nucleoside phosphorylase reveal it to be a homodimeric uridine phosphorylase. J Mol Biol 396:1244-1259.
34. Longley DB, Harkin DP, and Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330-338.
35. Lüscher A, De Koning HP, and Mäser P (2007a) Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting. Curr Pharm Des 13:555-567.
36. Lüscher A, Önal P, Schweingruber A-M, and Mäser P (2007b) Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites. Antimicrob Agents Chemother 51:3895-3901.
37. Moroz OV, Murzin AG, Makarova KS, Koonin EV, Wilson KS, and Galperin MY (2005) Dimeric DUT, His E, and Maz G Pases belong to a new superfamily of all-alpha NTP pyrophosphohydrolases with potential "house-cleaning" functions. J Mol Biol 347:243-255.
38. Natto MJ, Wallace LJM, Candlish D, Al-Salabi MI, Coutts SE, and De Koning HP (2005) Trypanosoma brucei: expression of multiple purine transporters prevents the development of allopurinol resistance. Exp Parasitol 109:80-86.
39. Papageorgiou IG, Yakob L, Al Salabi MI, Diallinas G, Soteriadou KP, and De Koning HP (2005) Identification of the first pyrimidine nucleobase transporter in Leishmania: similarities with the Trypanosoma brucei U1 transporter and antileishmanial activity of uracil analogues. Parasitology 130:275-283.
40. Rathod PK, Khatri A, Hubbert T, and Milhous WK (1989) Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 33:1090-1094.
41. Sanchez MA, Tryon R, Green J, Boor I, and Landfear SM (2002) Six related nucleoside/nucleobase transporters from Trypanosoma brucei exhibit distinct biochemical functions. J Biol Chem 277:21499-21504.
42. Scheltema RA, Jankevics A, Jansen RC, Swertz MA, and Breitling R (2011) PeakML/mzMatch: a file format, Java library, R library, and tool-chain for mass spec-trometry data analysis. Anal Chem 83:2786-2793.
43. Sienkiewicz N, Jarosławski S, Wyllie S, and Fairlamb AH (2008) Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes. Mol Microbiol 69:520-533.
44. Simarro PP, Cecchi G, Paone M, Franco JR, Diarra A, Ruiz JA, Fèvre EM, Courtin F, Mattioli RC, and Jannin JG (2010) The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 9:57.
45. Suzuki R and Shimodaira H (2006) Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22:1540-1542.
46. Tautenhahn R, Böttcher C, and Neumann S (2008) Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 9:504.
47. Teka IA, Kazibwe AJ, and El-Sabbagh N et al. (2011) The diamidine diminazene aceturate is a substrate for the high-affinity pentamidine transporter: implications for the development of high resistance levels in trypanosomes. Mol Pharmacol 80: 110-116.
48. Thompson JD, Gibson TJ, and Higgins DG (2002) Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics 2:2.3.
49. Van Dyke K, Tremblay GC, Lantz CH, and Szustkiewicz C (1970) The source of purines and pyrimidines in Plasmodium berghei. Am J Trop Med Hyg 19:202-208.
50. Wallace LJM, Candlish D, and De Koning HP (2002) Different substrate recognition motifs of human and trypanosome nucleobase transporters. Selective uptake of purine antimetabolites. J Biol Chem 277:26149-26156.
51. Wang CC and Cheng HW (1984) Salvage of pyrimidine nucleosides by Trichomonas vaginalis. Mol Biochem Parasitol 10:171-184.
52. Ward CP, Wong PE, Burchmore RJ, De Koning HP, and Barrett MP (2011) Trypa-nocidal furamidine analogues: influence of pyridine nitrogens on trypanocidal activity, transport kinetics, and resistance patterns. Antimicrob Agents Chemother 55:2352-2361.
53. Zhang T, Creek DJ, Barrett MP, Blackburn G, and Watson DG (2012) Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with Orbitrap mass spectrometry for metabolomic studies of human urine. Anal Chem 84:1994-2001.
54. Zhou J, Shen J, Liao D, Zhou Y, and Lin J (2004) Resistance to drug by different isolates Trypanosoma evansi in China. Acta Trop 90:271-275.